Zdrowie i gospodarka · 14/07/2015

FDA Releases Draft Guidance for Magnetic Resonance Diagnostic Devices

The Food and Drug Administration (FDA) has made available a draft guidance outlining the requirements for submitting premarket notifications for magnetic resonance diagnostic devices, as part of its efforts to provide clarity and consistency for industry and FDA staff.